FSTX - INVESTIGATION NOTICE: Halper Sadeh LLP Investigates RDUS FSTX EPZM

NEW YORK, NY / ACCESSWIRE / June 28, 2022 / Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to:

Radius Health, Inc. (NASDAQ:RDUS)'s sale to Gurnet Point Capital and Patient Square Capital. Under the terms of the merger agreement, Gurnet Point and Patient Square will acquire all of the outstanding shares of Radius for $10.00 per share in cash plus a Contingent Value Right of $1.00 per share payable upon TYMLOS® (abaloparatide) net sales reaching $300 million during any consecutive 12-month period prior to December 31, 2025.If you are a Radius shareholder, click here to learn more about your rights and options.

F-star Therapeutics, Inc. (NASDAQ:FSTX)'s sale to invoX Pharma for $7.12 per share. If you are a F-star shareholder, click here to learn more about your rights and options.

Epizyme, Inc. (NASDAQ:EPZM)'s sale to Ipsen. If you are an Epizyme shareholder, click here to learn more about your rights and options.

Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.

Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email sadeh@halpersadeh.com or zhalper@halpersadeh.com.

Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.

Attorney Advertising. Prior results do not guarantee a similar outcome.

Contact Information:

Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
sadeh@halpersadeh.com
zhalper@halpersadeh.com
https://www.halpersadeh.com

SOURCE: Halper Sadeh LLP